Emesis (Vomiting) – Drugs In Development, 2024
Powered by ![]()
Unlock hidden opportunities in the Pharmaceuticals industry
Empower your strategies with our Emesis (Vomiting) – Drugs In Development, 2024 report and make more profitable business decisions.
Emesis (vomiting) is the involuntary, forceful expulsion of the contents of one’s stomach through the mouth and sometimes the nose. Vomiting can be the result of ailments like food poisoning, gastroenteritis, pregnancy, motion sickness, or hangover; or it can be an after effect of diseases such as brain tumors, elevated intracranial pressure, or overexposure to ionizing radiation.
The Emesis (Vomiting) drugs in development market research report provide comprehensive information on the therapeutics under development for Emesis (Vomiting), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action and product description of the therapeutics, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Emesis (Vomiting) and features dormant and discontinued products.
Note:
* This is an “on-demand” report and will be delivered within 2 business days (excluding weekends and holidays) of the purchase.
* Certain sections in the report may be removed or altered based on the availability and relevance of data.
| Quick View – Emesis (Vomiting) | Key Targets |
|
|
| Key Mechanisms of Action |
|
||
| Key Routes of Administration |
|
||
| Key Molecule Types |
|
||
| Major Companies |
|
||
Scope
- Therapeutics in Development: Covering 13 molecules, with 12 developed by companies and the rest by universities/institutes.
- Analysis Parameters: Offering insights by stage of development, drug target, MoA, RoA, and molecule type for a comprehensive overview.
- Pharmacological Insights: Understand the descriptive pharmacological action of therapeutics.
- Development History: Access the complete research and development history.
- Latest News and Press Releases: Stay updated with the latest developments through comprehensive news coverage.
Reasons to Buy
- Holistic insights: Understand the broad spectrum of Emesis (Vomiting) therapeutics, aiding strategic decision-making with insights into stages, targets, MoA, RoA and molecule types.
- Pipeline Exploration: Explore the detailed Emesis (Vomiting) pipeline, offering nuanced analysis of drug targets, mechanisms of action and routes of administration for varied decision-making.
- Comprehensive R&D: Access thorough R&D histories, providing a comprehensive understanding of Emesis (Vomiting) treatments for adaptable decision-making.
- Save valuable hours: Identify key players steering innovation in therapeutics, enabling strategic partnerships.
Key Players
Alexza Pharmaceuticals IncAustin Biosciences Corp
Benuvia Therapeutics Inc
Charleston Laboratories Inc
Daewoo Pharmaceutical Co Ltd
HK inno.N Corp
Huons Co Ltd
Johns Hopkins University
Nasus Pharma Ltd
Neurocrine Biosciences Inc
Samyang Biopharmaceuticals Corp
Table of Contents
Table
Figures
Frequently asked questions
Related reports
View more Emesis (Vomiting) reports